Literature DB >> 30719679

Early Infectious Complications After Total Pancreatectomy with Islet Autotransplantation: a Single Center Experience.

Justyna E Gołębiewska1,2, Piotr J Bachul1,3, Natalie Fillman1, Mark R Kijek1, Lindsay Basto1, Monica Para1, Laurencia Perea1, Karolina Gołąb1, Ling-Jia Wang1, Martin Tibudan1, Alicja Dębska-Ślizień2, Jeffrey B Matthews1, John Fung1, Piotr Witkowski4.   

Abstract

INTRODUCTION: We assessed whether positive microbiological cultures from the islet preparation had any effect on the risk of infectious complications (IC) after total pancreatectomy with islet autotransplantation (TPIAT) in our center.
METHODS: We analyzed preservation fluid and final islet product surveillance cultures with reference to clinical data of patients undergoing TPIAT. All patients received routine prophylactic broad-spectrum antibiotics.
RESULTS: The study involved 10 men and 18 women with a median age of 39 years. Over 30% of surveillance cultures during pancreas processing grew bacterial strains with predominantly polymicrobial contaminations (13 of 22 (59%)). At least one positive culture was identified in almost half of the patients (46%) undergoing TPIAT and a third had both surveillance cultures positive. Infectious complications affected 50% of patients. After excluding cases of PICC line-associated bacteremia/fungemia present on admission, incidence of IC was higher in cases of positive final islet product culture than in those with negative result (57% vs. 21%), which also corresponded with the duration of chronic pancreatitis (p = 0.04). Surgical site infections were the most common IC, followed by fever of unknown origin. There was no concordance between pathogens isolated from the pancreas and those identified during the infection.
CONCLUSIONS: While IC was common among TPIAT patients, we found no concordance between pathogens isolated from the pancreas and those identified during infection. Contamination of the final islet product was of clinical importance and could represent a surrogate marker for higher susceptibility to infection.

Entities:  

Keywords:  Autologous islet transplantation; Infectious complications; Surveillance cultures; Total pancreatectomy with islet autotransplantation

Mesh:

Year:  2019        PMID: 30719679     DOI: 10.1007/s11605-019-04118-y

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  26 in total

1.  Positive sterility cultures of transplant solutions during pancreatic islet autotransplantation are associated infrequently with clinical infection.

Authors:  Kristin P Colling; Juan J Blondet; A N Balamurugan; Joshua J Wilhelm; Ty Dunn; Timothy L Pruett; David E R Sutherland; Srinath Chinnakotla; Melena Bellin; Greg J Beilman
Journal:  Surg Infect (Larchmt)       Date:  2015-02-10       Impact factor: 2.150

2.  Microbial contamination of clinical islet transplant preparations is associated with very low risk of infection.

Authors:  Boris Gala-Lopez; Tatsuya Kin; Doug O'Gorman; Andrew R Pepper; Peter Senior; Atul Humar; A M James Shapiro
Journal:  Diabetes Technol Ther       Date:  2013-02-25       Impact factor: 6.118

3.  Use of the BacT/alert system for rapid detection of microbial contamination in a pilot study using pancreatic islet cell products.

Authors:  Laura Murray; Neil McGowan; John Fleming; Laura Bailey
Journal:  J Clin Microbiol       Date:  2014-07-16       Impact factor: 5.948

4.  Risk of bacterial colonization of pancreatic stents used in endoscopic retrograde cholangiopancreatography.

Authors:  Sean K Hill; Christopher Bhalla; Andrew Thomson
Journal:  J Clin Gastroenterol       Date:  2012-04       Impact factor: 3.062

5.  Postoperative infectious complications after pancreatic resection.

Authors:  K Okano; T Hirao; M Unno; T Fujii; H Yoshitomi; S Suzuki; S Satoi; S Takahashi; O Kainuma; Y Suzuki
Journal:  Br J Surg       Date:  2015-09-21       Impact factor: 6.939

6.  The impact of bacterial colonization on graft success after total pancreatectomy with autologous islet transplantation: considerations for early definitive surgical intervention.

Authors:  Joshua S Jolissaint; Linda W Langman; Claire L DeBolt; Jacob A Tatum; Allison N Martin; Andrew Y Wang; Daniel S Strand; Victor M Zaydfudim; Reid B Adams; Kenneth L Brayman
Journal:  Clin Transplant       Date:  2016-10-17       Impact factor: 2.863

7.  Microbial contamination of transplant solutions during pancreatic islet autotransplants is not associated with clinical infection in a pediatric population.

Authors:  Megan G Berger; Kaustav Majumder; James S Hodges; Melena D Bellin; Sarah Jane Schwarzenberg; Sameer Gupta; Ty B Dunn; Gregory J Beilman; Timothy L Pruett; Martin L Freeman; Joshua J Wilhelm; David E R Sutherland; Srinath Chinnakotla
Journal:  Pancreatology       Date:  2016-04-06       Impact factor: 3.996

8.  Risk factors for early readmission after total pancreatectomy and islet auto transplantation.

Authors:  Rauf Shahbazov; Bashoo Naziruddin; Kunal Yadav; Giovanna Saracino; Gumpei Yoshimatsu; Mazhar A Kanak; Ernest Beecherl; Peter T Kim; Marlon F Levy
Journal:  HPB (Oxford)       Date:  2017-10-06       Impact factor: 3.647

9.  Autotransplantation of culture-positive islet product: is dirty always bad?

Authors:  Crystal N Johnson; Katherine A Morgan; Stefanie M Owczarski; Hongjun Wang; June Fried; David B Adams
Journal:  HPB (Oxford)       Date:  2013-12-06       Impact factor: 3.647

10.  Prophylactically Decontaminating Human Islet Product for Safe Clinical Application: Effective and Potent Method.

Authors:  Meirigeng Qi; Keiko Omori; Yoko Mullen; Brian McFadden; Luis Valiente; Jemily Juan; Shiela Bilbao; Bernard R Tegtmeier; Donald Dafoe; Fouad Kandeel; Ismail H Al-Abdullah
Journal:  Transplant Direct       Date:  2016-02
View more
  1 in total

1.  Pain resolution and glucose control in pediatric patients with chronic pancreatitis after total pancreatectomy with islet auto-transplantation.

Authors:  Damian Grybowski; Piotr J Bachul; Jordan S Pyda; Mark Kijek; Natalie Fillman; Angelica Perez-Gutierrez; Lindsay Basto; Karolina Golab; Ling-Jia Wang; Martin Tibudan; Aaron Lucander; Ruba Azzam; Jędrzej Chrzanowski; Wojciech Fendler; John Fung; Jeffrey B Matthews; Sajan Nagpal; Piotr Witkowski; Mark B Slidell
Journal:  Pediatr Surg Int       Date:  2021-07-10       Impact factor: 1.827

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.